Leaflet modification before transcatheter aortic valve implantation in patients at risk for coronary obstruction: the ShortCut study.
Danny DvirDidier TchétchéMartin B LeonPhilippe GénéreuxBenjamin SeguyRaj R MakkarPhillippe PibarotHemal GadaTamim M NazifDavid Hildick-SmithJoerg KempfertNicolas DumonteilAxel UnbehaunThomas ModineBrian WhisenantChristophe CaussinLenard ConradiThomas WaggonerJacob M MishellStanley J ChetcutiSaibal KarMichael J RinaldiMolly SzerlipRavi K RamanaDaniel J BlackmanItsik Ben-DorRan KornowskiRon WaksmanUlrich GerckensPaolo DentiMarian KukuckaJulien TernacleSabah SkafJan KovacHasan JilaihawiVivek PatelRami JubehMohamed Abdel-WahabSusheel KodaliPublished in: European heart journal (2024)
Modification of failed bioprosthetic aortic valve leaflets using ShortCut was safe, achieved successful leaflet splitting in all patients, and was associated with favorable clinical outcomes in patients at risk for coronary obstruction undergoing TAVI.
Keyphrases
- aortic valve
- transcatheter aortic valve implantation
- end stage renal disease
- aortic stenosis
- ejection fraction
- aortic valve replacement
- transcatheter aortic valve replacement
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- coronary artery
- heart failure
- patient reported outcomes
- left ventricular